J Robot Surg. 2025 Mar 7;19(1):103. doi: 10.1007/s11701-025-02255-y.
ABSTRACT
The objective is to compare the feasibility, safety, and complications of the novel robot-assisted system Hugo™ RAS to the established Intuitive da Vinci Xi system in different gynecologic surgeries. This is a retrospective and propensity score-matching study conducted at a tertiary teaching hospital. The participants were women with various indications for gynecologic surgery who underwent robotic procedures. The results of our first 40 cases of gynecologic procedures performed with Hugo™ RAS were compared to those of a 1:3 propensity-matched cohort using the da Vinci Xi system. Length of hospital stay, blood loss, surgical time, console time, and perioperative complications were the main outcome measures. There were no differences in the length of hospital stay, blood loss, and complication rates between the novel Hugo™ RAS and da Vinci Xi system in different gynecologic procedures. However, the surgical time was longer with Hugo™ RAS in the staging of endometrial cancer. The Hugo™ RAS is a feasible and safe robotic platform for different indications in gynecologic surgery.
PMID:40053244 | DOI:10.1007/s11701-025-02255-y
